Feng et al. [41] reported that JNK exerted its carcinogenic effect in human CCA cells, partially because the mammalian target of the rapamycin (mTOR) pathway was regulated by the induction of glucose-regulated protein 78 (GRP78). The gene discussed is HSPA5; the disease is cholangiocarcinoma.